View all news

Casper Reports First Quarter 2021 Results

05/13/2021

Record First Quarter Revenue of $127.7 million and First Quarter Gross Margin of 52.2%

20% YoY Growth in North America Revenue, Including 54% YoY Growth in Retail Partnership Channel

Company Raises Full Year 2021 Financial Outlook to Reflect Favorable Business Trends

NEW YORK--(BUSINESS WIRE)-- Casper Sleep Inc. (“Casper” or the “Company”) (NYSE: CSPR) today announced financial results for the quarter ended March 31, 2021 (the “first quarter 2021” or “first quarter”).

First Quarter 2021 Financial Highlights (as compared to the quarter ended March 31, 2020)

  • North America revenue increased 20.0% to a first quarter record of $127.7 million;
    • North America Direct-to-Consumer revenue, inclusive of Casper’s 70 retail stores and e-commerce channel, increased 11.1% to $93.2 million;
    • North America Retail Partnership revenue increased 53.7% to $34.4 million;
  • Gross Profit increased $13.7 million or 25.9% to $66.7 million with gross margin of 52.2%, up 540 basis points;
  • Net Loss improved $13.3 million or 38.5% to $21.2 million;
  • Adjusted EBITDA loss improved by $12.3 million or 54% to $10.6 million; and
  • Cash and cash equivalents were $61.6 million at quarter end.

Chief Executive Officer, Philip Krim, commented: “Casper delivered record first quarter financial results that exceeded our expectations, and that momentum has continued in the second quarter. Our third-party manufacturing model is enabling us to effectively navigate industry-wide supply chain challenges as we meet growing demand for our products. As a result, we continued outpacing the overall mattress industry, generating first quarter North American revenue growth of 20% year-over-year, including 54% growth in retail partnership revenue. Top-line growth, combined with our gross margin of over 52%, resulted in a 26% rise in gross profit and a meaningful improvement in Adjusted EBITDA, reinforcing our expectation that Casper will achieve Adjusted EBITDA profitability in the second half of 2021.”

Mr. Krim continued, “In the second quarter, we continue to successfully execute on our three core strategic priorities including: expanding our product offering with the launch of our new Casper Cooling Collection, increasing brand awareness with the introduction of the new ‘Love Your Tomorrow’ brand platform, and growing points of retail distribution. We continue to see strong demand signals across our business, and expect top-line growth to accelerate in the coming quarters and are raising our full year 2021 financial outlook to reflect these favorable trends. With the significant opportunities in front of us, we remain confident in our ability to achieve our growth and profitability goals, as we build on our recent progress to best position Casper for the future.”

Outlook

The Company today provided an outlook for certain financial metrics for the quarter ending June 30, 2021 (“second quarter 2021”) and year ending December 31, 2021 (“full year 2021” or “2021”), reflecting certain assumptions by management regarding the Company’s business, trends, seasonal factors, and the continuing impact of the COVID-19 pandemic on its business. In addition, the outlook assumes there will be no material changes in world events, recent consumer trends, economic conditions, competitive landscape or other circumstances beyond our control that may adversely affect the Company’s results of operations.

In the second quarter 2021, the Company expects revenue of approximately $146 to $153 million, net loss of approximately $18 to $15 million, and Adjusted EBITDA loss of approximately $7 to $4 million. At the mid-point, this revenue range represents 36% growth and 42% North America revenue growth in the second quarter 2021. For the full year 2021, the Company expects revenue of approximately $580 to $610 million. At the mid-point, this revenue range represents 20% growth and 23% North America revenue growth for 2021.

Conference Call & Webcast Information

Casper will hold a conference call on Thursday, May 13, 2021, at 8:00 a.m. Eastern time to discuss the Company’s first quarter results and other business updates. To access the conference call, interested parties may dial 866-319-1799 (for domestic callers) or 825-312-2362 (for international callers). Please call at least five minutes in advance of the start of the call to ensure that you are connected prior to the call. Interested parties may also access a live audio webcast of the call at https://ir.casper.com/news-and-events/events-and-presentations/default.aspx. Please allow 15 minutes to register. A replay of the call will be available within two hours of the conclusion of the call until July 12, 2021 at https://ir.casper.com/news-and-events/events-and-presentations/default.aspx

Casper periodically provides information for investors on its corporate website, casper.com, and its investor relations website, ir.casper.com. This includes press releases and other information about financial performance, reports filed or furnished with the SEC and information on corporate governance.

About Casper

Casper believes everyone should sleep better. The Sleep Company has a full portfolio of obsessively engineered sleep products—including mattresses, pillows, bedding, and furniture designed in-house by the Company’s award-winning R&D team at Casper Labs. In addition to its e-commerce business, Casper owns and operates Sleep Shops across North America and its products are available at a growing list of retailers.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations surrounding the impact of the COVID-19 pandemic and the related effect on our employees, customers and business operations; our expectations surrounding our ability to deliver growth, gain market share, and achieve Adjusted EBITDA profitability by specified timelines; our future competitive position; our future results of operations and financial position including our outlook for the second quarter 2021 and full year 2021; our business strategy and plans, including our plans regarding product launches, expanding brand awareness and reach, and our retail distribution; and objectives of management for future operations and creating long-term value. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: the COVID-19 pandemic could adversely impact our business, financial condition and results of operations; our ability to compete successfully in the highly competitive industries in which we operate; our ability to maintain and enhance our brand; the success of our retail store expansion plans; our ability to successfully implement our growth strategies related to launching new products; the effectiveness and efficiency of our marketing programs; our ability to manage our current operations and to manage future growth effectively; our past results may not be indicative of our future operating performance; our ability to manage our supply chain commensurate with demand and successfully and timely deliver merchandise to our retail partners and customers; our ability to attract new customers or retain existing customers; the growth of the market for sleep as a retail category and our ability to become a leader or maintain our leadership in the category; the impact of social media and influencers on our reputation; our ability to protect and maintain our intellectual property; our exclusive reliance on third-party contract manufacturers whose efforts we are unable to fully control; our ability to effectively implement strategic initiatives; our ability to transfer our supply chain and other business processes to a global scale; risks relating to our international operations and expansion; we are dependent on our retail partners; general economic and business conditions; we could be subject to system failures or interruptions and security breaches; risks relating to changing legal and regulatory requirements, and any failure to comply with applicable laws and regulations; we may be subject to product liability claims and other litigation; we may experience fluctuations in our quarterly operating results; we have and expect to continue to incur significant losses; risks relating to our indebtedness; our need for additional funding, which may not be available; risks relating to taxes; future sales by us our stockholders may cause the market price of our stock to decline; and risks and additional costs relating to our status as a new public company. These and other important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and our other filings with the Securities and Exchange Commission could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Non-GAAP Financial Measures

Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presented in accordance with, GAAP. Adjusted EBITDA is not a measurement of our financial performance under GAAP and should not be considered as an alternative to net income or any other performance measure derived in accordance with GAAP.

We define Adjusted EBITDA as net loss before interest (income) expense, income tax expense and depreciation and amortization as further adjusted to exclude the impact of stock-based compensation expense, restructuring costs, costs associated with legal settlements, and transaction costs incurred in connection with our initial public offering. We caution investors that amounts presented in accordance with our definition of Adjusted EBITDA may not be comparable to similar measures disclosed by our competitors, because not all companies and analysts calculate Adjusted EBITDA in the same manner. We present Adjusted EBITDA because we consider it to be an important supplemental measure of our performance and believe it is frequently used by securities analysts, investors, and other interested parties in the evaluation of companies in our industry. Management believes that investors’ understanding of our performance is enhanced by including this non-GAAP financial measure as a reasonable basis for comparing our ongoing results of operations.

Management uses Adjusted EBITDA:

  • as a measurement of operating performance because it assists us in comparing the operating performance of our business on a consistent basis, as it removes the impact of items not directly resulting from our core operations;
  • for planning purposes, including the preparation of our internal annual operating budget and financial projections;
  • to evaluate the performance and effectiveness of our operational strategies; and
  • to evaluate our capacity to expand our business.

By providing this non-GAAP financial measure, together with the reconciliation, we believe we are enhancing investors’ understanding of our business and our results of operations, as well as assisting investors in evaluating how well we are executing our strategic initiatives. Adjusted EBITDA has limitations as an analytical tool, and should not be considered in isolation, or as an alternative to, or a substitute for net income or other financial statement data presented in our consolidated financial statements as indicators of financial performance. Some of the limitations are:

  • such measure does not reflect our cash expenditures;
  • such measure does not reflect changes in, or cash requirements for, our working capital needs;
  • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and such measures do not reflect any cash requirements for such replacements; and
  • other companies in our industry may calculate such measures differently than we do, limiting their usefulness as comparative measures.

Due to these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our GAAP results and using this non-GAAP measure only supplementally. As noted in the table below, Adjusted EBITDA includes adjustments to exclude the impact of stock-based compensation expense and material infrequent items, including but not limited to the costs of our initial public offering, restructuring, and costs associated with legal settlements, among other items. It is reasonable to expect that these items will occur in future periods. However, we believe these adjustments are appropriate because the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing operations of our business and may complicate comparisons of our internal operating results and operating results of other companies over time. In addition, Adjusted EBITDA includes adjustments for other items that we do not expect to regularly record following our initial public offering. Each of the normal recurring adjustments and other adjustments described in this paragraph and in the reconciliation table below help management with a measure of our core operating performance over time by removing items that are not related to day-to-day operations.

Casper Sleep Inc. and Subsidiaries

Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

 

As of

Assets

March 31, 2021

 

December 31, 2020

Current assets:

 

 

 

Cash and cash equivalents

$

61,626

 

 

$

88,922

 

Restricted Cash

 

 

3,162

 

Accounts receivable, net

24,536

 

 

27,663

 

Prepaid expenses and other current assets

12,840

 

 

11,026

 

Inventory, net

46,840

 

 

35,531

 

Total current assets

145,842

 

 

166,304

 

Property and equipment, net

66,193

 

 

66,529

 

Other assets

1,363

 

 

1,368

 

Total assets

$

213,398

 

 

$

234,201

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

48,130

 

 

$

47,612

 

Accrued expenses

56,238

 

 

54,741

 

Deferred revenue

4,109

 

 

7,430

 

Other current liabilities

10,001

 

 

9,498

 

Total current liabilities

118,478

 

 

119,281

 

Long-term Debt

62,966

 

 

65,546

 

Other liabilities

23,833

 

 

23,907

 

Total liabilities

205,277

 

 

208,734

 

Stockholders’ equity:

 

 

 

Common stock, $0.000001 par value - 170,000 and 170,000 shares authorized;
41,425 and 40,539 issued and outstanding as of
March 31, 2021 and December 31, 2020, respectively

 

 

 

Additional paid-in capital

444,063

 

 

440,248

 

Accumulated other comprehensive income

53

 

 

34

 

Accumulated deficit

(435,995)

 

 

(414,815)

 

Total stockholders’ equity

8,121

 

 

25,467

 

Total liabilities and stockholders’ equity

$

213,398

 

 

$

234,201

 

Casper Sleep Inc. and Subsidiaries

Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except share and per share amounts)

(Unaudited)

 

Three Months Ended March 31,

 

2021

 

2020

Revenue

$

127,678

 

 

$

113,044

 

Cost of goods sold

60,995

 

 

60,080

 

Gross profit

66,683

 

 

52,964

 

Operating expenses

 

 

 

Sales and marketing expenses

40,530

 

 

37,474

 

General and administrative expense

44,504

 

 

46,987

 

Restructuring expenses

401

 

 

1,311

 

Total operating expenses

85,435

 

 

85,772

 

Loss from operations

(18,752)

 

 

(32,808)

 

Other (income) expense

 

 

 

Net interest expense

2,516

 

 

2,156

 

Other (income) expense, net

(107)

 

 

(514)

 

Total other expenses, net

2,409

 

 

1,642

 

Loss before income taxes

(21,161)

 

 

(34,450)

 

Income tax expense

19

 

 

16

 

Net loss

(21,180)

 

 

(34,466)

 

Other comprehensive income (loss)

 

 

 

Currency translation adjustment

19

 

 

447

 

Total comprehensive loss

$

(21,161)

 

 

$

(34,019)

 

 

 

 

 

Net loss per share attributable to common stockholders, basic and diluted

$

(0.52)

 

 

$

(1.23)

 

Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic and diluted

40,808,328

 

 

27,909,141

 

Casper Sleep Inc. and Subsidiaries

Consolidated Statement of Cash Flows

(In thousands)

(Unaudited)

 

Three Months Ended March 31,

 

2021

 

2020

Cash flows used in operating activities:

 

 

 

Net loss

$

(21,180)

 

 

$

(34,466)

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Depreciation and amortization

3,823

 

 

4,129

 

Stock based compensation expense

3,786

 

 

2,661

 

Other

768

 

 

423

 

Changes in assets and liabilities:

 

 

 

Accounts receivable, net

3,127

 

 

10,637

 

Prepaid expenses and other current assets

(1,815)

 

 

110

 

Inventory, net

(11,914)

 

 

486

 

Other assets

(1)

 

 

95

 

Accounts payable

913

 

 

7,113

 

Accrued expenses

1,497

 

 

(17,771)

 

Deferred revenue

(3,322)

 

 

(5,842)

 

Other liabilities

692

 

 

(643)

 

Net cash used in operating activities

(23,626)

 

 

(33,068)

 

Cash flows used in investing activities:

 

 

 

Purchases of property and equipment

(3,881)

 

 

(7,090)

 

Net cash used in investing activities

(3,881)

 

 

(7,090)

 

Cash flows (used in) provided by financing activities:

 

 

 

Exercise of stock options and warrants

29

 

 

50

 

Proceeds from equity issuance

 

 

88,206

 

Repayment on borrowings

(3,000)

 

 

 

Net cash (used in) provided by financing activities

(2,971)

 

 

88,256

 

Effect of exchange rate changes

20

 

 

447

 

Net change in cash, cash equivalents, and restricted cash

(30,458)

 

 

48,545

 

Cash, cash equivalents, and restricted cash at beginning of period

92,084

 

 

67,578

 

Cash, cash equivalents, and restricted cash at end of the period

$

61,626

 

 

$

116,123

 

 

 

 

 

Supplemental disclosure of cash paid for:

 

 

 

Interest paid

$

(1,554)

 

 

$

(1,180)

 

Casper Sleep Inc. and Subsidiaries

Reconciliation of Non-GAAP Metrics

(In thousands)

(unaudited)

 

Three Months Ended

March 31,

(in thousands)

2021

 

2020

Net loss

$

(21,180)

 

 

$

(34,466)

 

Income tax expense

19

 

 

16

 

Interest (income) expense

2,516

 

 

2,156

 

Depreciation and amortization

3,823

 

 

3,148

 

Stock based compensation(a)

3,786

 

 

2,661

 

Restructuring(b)

401

 

 

1,311

 

Legal settlements(c)

 

 

1,500

 

Transaction costs(d)

 

 

787

 

Adjusted EBITDA

$

(10,636)

 

 

$

(22,887)

 

 

Three Months Ended
June 30, 2020

Three Months Ended
June 30, 2021 Estimated

(in thousands)

Actual

Low

High

Net loss

(24,205)

 

(17,745)

 

(14,745)

 

Income tax expense

10

 

 

 

Interest (income) expense

2,152

 

2,270

 

2,270

 

Depreciation and amortization

3,195

 

4,550

 

4,550

 

Stock-based compensation(a)

3,284

 

3,925

 

3,925

 

Restructuring(b)

4,129

 

 

 

Legal settlements(c)

 

 

 

Transaction costs(d)

 

 

 

Adjusted EBITDA

$

(11,435)

 

$

(7,000)

 

$

(4,000)

 

 

(a) Represents non-cash stock-based compensation expense.

(b) Represents costs associated with strategic shifts in our business structure including exiting certain lines of business and geographies. Associated costs include severance and other employee separation costs, contract termination expenses and asset impairment.

(c) Amounts related to litigation settlements.

(d) Represents expenses incurred for professional, consulting, legal, and accounting services performed in connection with our initial public offering, which are not indicative of our ongoing costs and which were discontinued following the completion of our initial public offering.

Press
comms@casper.com

Investor Relations
IR@casper.com

Source: Casper Sleep Inc.

Multimedia Files:

Categories: Press Releases
View all news